Pharmacy Podcast Network

In the next episode of the Counter Talk™ Podcast host Jason Callori talks with Cardinal Health's Morgan McCullough about the upcoming Drug Supply Chain Security Act (DSCSA) regulations taking effect later this year. Morgan and Jason discuss these requirements, the changes Cardinal Health is making to remain compliant and what those changes mean for you and your pharmacy. 

How can partnering with a leading reverse distribution company help you be more profitable? Have you ever thought about increasing revenue with Functional Medicine? This podcast is packed with knowledge leaders in both topics on ‘This Week in Pharmacy’   

Thousands of pharmacists gathered in Phoenix on March 24-27, 2023, for the APhA 2023 to connect, learn and rise together! Thank you for joining us at #APhA2023 and making our Annual Meeting an event to remember! Pharmacy Podcast Network was in full support of the 'Locked on Pharmacy' podcast, the official podcast of the American Pharmacists Association. Be sure to listen to these amazing innovators of Pharmacy care:    Episode 2   ·             Michael Hoge (Incoming CEO and Executive Vice President Michael Hogue, , PharmD, FAPhA, FNAP, FFIP.) ·             Lydia Bailey (Keynote panel) ·             Danielle James (Keynote panel) ·             Sarah Crowel- P2 Student Pharmacist/Diabetes/Omnipod tech ·             Dean Muensterman-Omnipod/Sponsor/Automated Insulin management ·             Shane Garrettson- Graduating pharmacist/Let’s pharmanize podcast

DYPD is a gene that provides instructions for making an enzyme called dihydropyrimidine dehydrogenase (DPD). This enzyme plays very important in breaking down a substance called uracil, which is found in our DNA and RNA. Mutations in the DYPD gene can lead to decreased or absent DPD activity, which if you think about it can cause a buildup of uracil in the body.  If someone is DPD deficiency it can make it difficult for the body to process certain chemotherapy drugs and can lead to severe side effects, such as nerve damage, GI problems, and even death. Genetic testing before being placed on a chemo agent, to see if there is a DPD deficiency is vital.  According to Advocates for Universal DPD/DPYD Testing (AUDT), Europe is becoming the standard of care for testing for this gene and only in some selected institutions in the US the testing it being done.  AUDT is made up of a group of patient advocates and medical professionals who are seeking to improve treatment outcomes for patients that are preparing to receive chemotherapy based on fluoropyrimidine drugs. One of the founders of this non-profit organization, AUDT, Karen Merritt is our guest today. She lost her mother in 2014 due to being DPD deficient and after getting her first infusion of 5FU. Karen dedicated herself to advocating and raising awareness about pre-testing for DPD deficiency before fluoropyrimidine chemotherapy administration to reduce unnecessary suffering. Resources: https://test4dpd.org/about-us/ Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.

Marc Essensa, the new CEO of IPC shares some of, "What’s New at IPC".  As the largest of the independent pharmacy GPO's you’ll want to listen to this podcast even if you’re not an IPC member.   Essensa, talks with PPN Founder, Todd Eury, and podcast host, Bruce Kneeland, about how IPC, under the direction of the group’s Board of Directors, all of whom own pharmacies, are working to “future proof” pharmacy.  Essensa discusses his background in logistics and pharmaceutical procurement and tells how that will enhance IPC’s purchasing power.  He also lays out IPC’s strategy for launching several new services that will simplify the way pharmacy owners can offer them to their patients.   Marc Essensa, CEO, The Independent Pharmacy Cooperative 

This 2020 report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group presents focused updates to the previous 2007 asthma management guidelines on six priority topics. Dr. Stephen J. Teach Biography Stephen J. Teach, M.D., M.P.H., is the associate dean for Pediatric Faculty Affairs and chair of the department of Pediatrics at George Washington University School of Medicine and Health Sciences; and director and principal investigator of IMPACT DC (Improving Pediatric Asthma Care in the District of Columbia), a care, research, and advocacy program focused on under-resourced and largely minority children with asthma. Dr. Teach also serves as the Washington, D.C., site principal investigator for the NIH/NIAID-funded Inner City Asthma Consortium. Dr. Teach’s primary academic focus is on inequities in care and outcomes for urban youth with asthma and their families, including their limited access to healthcare services that often results in families seeking episodic asthma care in emergency department settings. file:///Users/jenaquinn/Downloads/Asthma%20Clinicians%20Guide%20508_02-03-21.pdf https://www.nhlbi.nih.gov/resources/2020-focused-updates-asthma-management-guidelines  

Thousands of pharmacists gathered in Phoenix on March 24-27, 2023, for the APhA 2023 to connect, learn and rise together! Thank you for joining us at #APhA2023 and making our Annual Meeting an event to remember! Pharmacy Podcast Network was in full support of the 'Locked on Pharmacy' podcast, the official podcast of the American Pharmacists Association. Be sure to listen to these amazing innovators of Pharmacy care:    ·             Namit Jindal (Emcee) ·             Inky Johnson (Keynote) ·             Theresa Tolle (Former President) ·             Dr. Starlin Hading Greating: APhA Pac discussion/importance ·             Jefferey Nye- Moving the profession forward discussion/Retired Fed Pharmacist

Independent Community Pharmacy must begin thriving through other non-prescription based revenue sources. We talk with Dr. Lisa Faast, pharmacy owner and founder of DiversityRx, leading a band of pharmacy owners into a whole other level of profitability. Next, we talk with Josh and Steve founders of the Cannabis Pharmacy and the future of pharmacist’s leading cannabis and cbd supplements and treatments. Our special bonus guest is Marc Essensa, Independent Pharmacy Cooperative new CEO and his plans for supporting the next generation independent pharmacy owners.

Naloxone! Literally everywhere! Naloxone is now OTC, so what now??? The PAIN GUY™ will discuss all things opioid antagonists including naloxone, naltrexone, and even nalmefene in this episode of the PAIN POD! This episode is for all of society, with the usual sprinkle of pharmacology. Come one, come all, to the Pain Pod!!! References • https://www.medpagetoday.com/neurology/generalneurology/60632 • Moss, R.B., Carlo, D.J. Higher doses of naloxone are needed in the synthetic opioid era. Subst Abuse Treat Prev Policy 14, 6 (2019).  • https://www.cnn.com/2018/11/06/health/naloxone-expiration-date-potency-study/index.html • Hossain MF, Rashid M, Mullins R, Davis T, Kimble C, Sarkar S; Charles “CK” Babcock. Chemical stability of naloxone products beyond their labeled expiration dates. J Opioid Manag. 2022 Jan-Feb;18(1):39-46. • Comparison of Relapse Rates Between Drug Addiction and Other Chronic Illnesses JAMA. 284: 1689-1695, 2000. • https://www.vice.com/en/article/qv7jmp/heroin-overdose-parties-are-a-dehumanizing-myth • https://naloxoneautoinjector.com/ • https://www.statnews.com/2023/03/28/opioid-overdose-naloxone-industry-profits/ • Katzman JG, Takeda MY, Bhatt SR, Moya Balasch M, Greenberg N, Yonas H. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study. J Addict Med. 2018 Mar/Apr;12(2):113-118. • Hatfield E, et. al. Use of low-dose naltrexone in the management of chronic pain conditions. JADA. December 2020. JADA 151(12). • https://www.reuters.com/business/healthcare-pharmaceuticals/addiction-drug-shows-promise-lifting-long-covid-brain-fog-fatigue-2022-10-18/ • https://www.painmedicinenews.com/Online-First/Article/09-21/FDA-Orphan-Drug-Low-Dose-Naltrexone/64707 • https://www.investopedia.com/ask/answers/06/orphandrugstatus.asp • https://www.statnews.com/2023/03/28/opioid-overdose-naloxone-industry-profits/

Welcome back to episode 3 of this season of the Holistic Pharmacy Podcast. I can’t wait to showcase the incredible lineup of guests for you this season! Today I’m sharing a TON of value about dieting, fasting, and metabolism with powerful information and insight from Dr. Ashley Dwyer. She is a Pharmacist, ACE Certified Health Coach, and former NPC athlete who after going through a slew of her own health issues due to extreme lifestyle habits, left the traditional western medical model to start her own company and really help others through holistic healing. Her team, TeamBDN coaching, specializes in holistic nutrition, macro tracking, metabolic restoration, individualized fitness plans, accountability, and community, helping women eat more and reach their health goals. Dr. Ashley is also certified in plant-based nutrition, Health Mindset Coaching, and Functional Nutrition and Metabolic Science. Her goal is to help as many individuals as she can feel their best and reverse years of metabolic adaptation. So without further ado, let’s welcome her to the show!